| human | Q5 |
| P496 | ORCID iD | 0000-0002-1006-2112 |
| P1053 | ResearcherID | Y-7065-2019 |
| P1153 | Scopus author ID | 7005044414 |
| P734 | family name | Cornel | Q37203475 |
| Cornel | Q37203475 | ||
| Cornel | Q37203475 | ||
| P735 | given name | Jan | Q12173670 |
| Jan | Q12173670 | ||
| P106 | occupation | researcher | Q1650915 |
| P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
| P21 | sex or gender | male | Q6581097 |
| Q37494353 | A Phase 2, randomized, partially blinded, active-controlled study assessing the efficacy and safety of variable anticoagulation reversal using the REG1 system in patients with acute coronary syndromes: results of the RADAR trial |
| Q80457454 | A man with diabetes and heart failure |
| Q83398624 | A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR |
| Q91960551 | ALCAM predicts future cardiovascular death in acute coronary syndromes: Insights from the PLATO trial |
| Q43711816 | Abnormal contractile responses during dobutamine stress echocardiography in patients with idiopathic dilated cardiomyopathy. |
| Q36890093 | Accuracy of currently available techniques for prediction of functional recovery after revascularization in patients with left ventricular dysfunction due to chronic coronary artery disease: comparison of pooled data |
| Q36834335 | Accuracy of dobutamine stress echocardiography for the diagnosis of coronary artery stenosis in patients with myocardial infarction: the impact of extent and severity of left ventricular dysfunction |
| Q36014180 | Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer-Alkmaar heart failure study |
| Q78169438 | Agreement and disagreement between "metabolic viability" and "contractile reserve" in akinetic myocardium |
| Q71192252 | Akinesis becoming dyskinesis during dobutamine stress echocardiography. A predictor of poor functional recovery after surgical revascularization |
| Q72423687 | Akinesis becoming dyskinesis during high-dose dobutamine stress echocardiography: a marker of myocardial ischemia or a mechanical phenomenon? |
| Q57058796 | Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial |
| Q91213464 | Alirocumab Reduces Total Hospitalizations and Increases Days Alive and Out of Hospital in the ODYSSEY OUTCOMES Trial |
| Q92535620 | Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome: ODYSSEY OUTCOMES Trial |
| Q51013364 | Altered myocardial perfusion during dobutamine stress testing in silent versus symptomatic myocardial ischaemia assessed by quantitative MIBI SPET imaging. |
| Q90759644 | Anti-Inflammatory Therapy With Canakinumab for the Prevention of Hospitalization for Heart Failure |
| Q35589442 | Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trial |
| Q38606033 | Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease |
| Q34202772 | Apixaban with antiplatelet therapy after acute coronary syndrome |
| Q71125996 | Assessment of patients after coronary artery bypass grafting by dobutamine stress echocardiography |
| Q38389880 | Association Between Sitagliptin Use and Heart Failure Hospitalization and Related Outcomes in Type 2 Diabetes Mellitus: Secondary Analysis of a Randomized Clinical Trial |
| Q91246759 | Associations between β-blocker therapy and cardiovascular outcomes in patients with diabetes and established cardiovascular disease |
| Q47689113 | Balancing the risk of spontaneous ischemic and major bleeding events in acute coronary syndromes |
| Q38442214 | Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibi |
| Q74485239 | Biphasic response to dobutamine predicts improvement of global left ventricular function after surgical revascularization in patients with stable coronary artery disease: implications of time course of recovery on diagnostic accuracy |
| Q45124516 | Bleeding complications with the P2Y12 receptor antagonists clopidogrel and ticagrelor in the PLATelet inhibition and patient Outcomes (PLATO) trial |
| Q84119071 | Calibration-free quantitative application of in situ Raman spectroscopy to a crystallization process |
| Q73232103 | Cardiac 18F-FDG-SPET studies in patients with non-insulin-dependent diabetes mellitus during hyperinsulinaemic euglycaemic clamping |
| Q50944763 | Cardiac imaging for risk stratification with dobutamine-atropine stress testing in patients with chest pain. Echocardiography, perfusion scintigraphy, or both? |
| Q47691483 | Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial |
| Q99632020 | Colchicine Attenuates Inflammation Beyond the Inflammasome in Chronic Coronary Artery Disease: A LoDoCo2 Proteomic Substudy |
| Q99632562 | Colchicine in Patients with Chronic Coronary Disease |
| Q58615940 | Colchicine in Stable Coronary Artery Disease |
| Q36859579 | Comparison between 360 degrees and 180 degrees data sampling in thallium-201 rest-redistribution single-photon emission tomography to predict functional recovery after revascularization |
| Q44303759 | Comprehensive analysis of aortic valve vegetation with anyplane, paraplane, and three-dimensional echocardiography |
| Q34419123 | Coronary artery disease in patients with atypical chest pain with and without diabetes mellitus assessed with coronary CT angiography |
| Q46001930 | Coronary artery pseudoaneurysm: closure with pericardium-covered stents, guided by cardiac computed tomography angiography. |
| Q71073964 | Coronary-artery bypass surgery with internal-thoracic-artery grafts |
| Q72436972 | Correlation of coronary stenosis by quantitative coronary arteriography with exercise echocardiography |
| Q48024330 | Cystatin C for enhancement of risk stratification in non-ST elevation acute coronary syndrome patients with an increased troponin T. |
| Q86859136 | Dehiscence of mitral valve annuloplasty: a three-dimensional diagnosis |
| Q73297025 | Delayed recovery of hibernating myocardium after surgical revascularization: implications for discrepancy between metabolic imaging and dobutamine echocardiography for assessment of myocardial viability |
| Q68047112 | Detection of left coronary artery stenosis by transoesophageal echocardiography |
| Q40986943 | Diagnostic and Therapeutic Usefulness of Coronary Computed Tomography Angiography in Out-Clinic Patients Referred for Chest Pain |
| Q52895799 | Digoxin in patients with heart failure. |
| Q40907622 | Discriminative Power of the HEART Score for Obstructive Coronary Artery Disease in Acute Chest Pain Patients Referred for CCTA. |
| Q45769001 | Diverging associations of an intended early invasive strategy compared with actual revascularization, and outcome in patients with non-ST-segment elevation acute coronary syndrome: the problem of treatment selection bias |
| Q73175562 | Dobutamine stress-redistribution-reinjection versus rest-redistribution thallium-201 SPECT in the assessment of myocardial viability |
| Q36737110 | Dobutamine-atropine stress echocardiography and clinical data for predicting late cardiac events in patients with suspected coronary artery disease |
| Q72889691 | Dobutamine-atropine stress echocardiography in elderly patients unable to perform an exercise test. Hemodynamic characteristics, safety, and prognostic value |
| Q77492668 | Dobutamine-atropine stress myocardial perfusion SPECT imaging in the diagnosis of graft stenosis after coronary artery bypass grafting |
| Q51043175 | Dobutamine-induced hypoperfusion without transient wall motion abnormalities: less severe ischemia or less severe stress? |
| Q79634666 | Dutch Randomized Trial on Off-Site Primary PCI |
| Q28191886 | Early invasive versus selectively invasive management for acute coronary syndromes |
| Q77772968 | Echocardiographic studies of dobutamine-induced ST-segment elevation before and after coronary artery bypass grafting in patients with old Q-wave myocardial infarction |
| Q92708835 | Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome |
| Q92223274 | Effect of Alirocumab on Mortality After Acute Coronary Syndromes |
| Q38384675 | Effect of Evolocumab on Progression of Coronary Disease in Statin-Treated Patients: The GLAGOV Randomized Clinical Trial |
| Q39289728 | Effect of Sitagliptin on Kidney Function and Respective Cardiovascular Outcomes in Type 2 Diabetes: Outcomes From TECOS. |
| Q73014647 | Effect of coronary artery bypass surgery on myocardial perfusion and ejection fraction response to inotropic stimulation in patients without improvement in resting ejection fraction |
| Q38601785 | Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial |
| Q28378044 | Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) |
| Q69436680 | Effect of papaverine administration on myocardial echocontrast distribution |
| Q38400558 | Effect of the REG1 anticoagulation system versus bivalirudin on outcomes after percutaneous coronary intervention (REGULATE-PCI): a randomised clinical trial |
| Q43488610 | Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial |
| Q92990025 | Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery |
| Q92241544 | Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial |
| Q61401722 | Effects of vorapaxar on platelet reactivity and biomarker expression in non-ST-elevation acute coronary syndromes |
| Q42913383 | Elevated admission glucose is associated with increased long-term mortality in myocardial infarction patients, irrespective of the initially applied reperfusion strategy |
| Q44314878 | Endothelial dysfunction and reduced myocardial perfusion reserve in heart failure secondary to coronary artery disease |
| Q72005546 | Evaluation by quantitative 99m-technetium MIBI SPECT and echocardiography of myocardial perfusion and wall motion abnormalities in patients with dobutamine-induced ST-segment elevation |
| Q47558126 | Exercise Electrocardiogram Neither Predicts Nor Excludes Coronary Artery Disease in Women with Low to Intermediate Risk |
| Q68084710 | Exercise echocardiography versus thallium-201 SPECT for assessing patients before and after PTCA |
| Q43155387 | Experimental evidence of a delta-shock in nonlinear chromatography |
| Q47745830 | Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial |
| Q73649940 | F18-fluorodeoxyglucose single-photon emission computed tomography predicts functional outcome of dyssynergic myocardium after surgical revascularization |
| Q35129963 | GRACE and TIMI risk scores but not stress imaging predict long-term cardiovascular follow-up in patients with chest pain after a rule-out protocol |
| Q46008915 | Glycoprotein IIb/IIIa Receptor Inhibitors in Combination With Vorapaxar, a Platelet Thrombin Receptor Antagonist, Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes (from the TRACER Trial). |
| Q36222401 | Heart failure programmes in countries with a primary care-based health care system. Are additional trials necessary? Design of the DEAL-HF study |
| Q73537957 | Hemodynamic changes, plasma catecholamine responses, and echocardiographically detected contractile reserve during two different dobutamine-infusion protocols |
| Q51120983 | High-pitch prospective ECG-triggered helical coronary computed tomography angiography in clinical practice: image quality and radiation dose. |
| Q64103474 | Impact of Diabetes Mellitus and Chronic Kidney Disease on Cardiovascular Outcomes and Platelet P2Y Receptor Antagonist Effects in Patients With Acute Coronary Syndromes: Insights From the PLATO Trial |
| Q41528609 | Impact of chronic kidney disease on long-term ischemic and bleeding outcomes in medically managed patients with acute coronary syndromes: Insights from the TRILOGY ACS Trial |
| Q73227430 | Impact of severity of coronary artery stenosis and the collateral circulation on the functional outcome of dyssynergic myocardium after revascularization in patients with healed myocardial infarction and chronic left ventricular dysfunction |
| Q50454126 | Impact of smoking status on platelet function and clinical outcomes with prasugrel vs. clopidogrel in patients with acute coronary syndromes managed without revascularization: Insights from the TRILOGY ACS trial. |
| Q43680779 | Impaired glucose metabolism predicts mortality after a myocardial infarction |
| Q73257406 | Improved detection of viable myocardium with fluorodeoxyglucose-labeled single-photon emission computed tomography in a patient with hibernating myocardium: comparison with rest-redistribution thallium 201-labeled single-photon emission computed tom |
| Q57779545 | Improved identification of coronary artery disease in patients with left bundle branch block by use of dobutamine stress echocardiography and comparison with myocardial perfusion tomography |
| Q77983443 | Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography |
| Q42646632 | In search of an efficient strategy to monitor disease status of chronic heart failure outpatients: added value of blood biomarkers to clinical assessment. |
| Q36823443 | Independent prognostic value of coronary artery calcium score and coronary computed tomography angiography in an outpatient cohort of low to intermediate risk chest pain patients |
| Q47219570 | Infarct size in primary angioplasty without on-site cardiac surgical backup versus transferal to a tertiary center: a single photon emission computed tomography study |
| Q88791363 | Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease |
| Q51063077 | Inhibition of nonlinear acoustic cavitation dynamics in liquid CO2. |
| Q38444911 | Intensive glucose regulation in hyperglycemic acute coronary syndrome: results of the randomized BIOMarker study to identify the acute risk of a coronary syndrome-2 (BIOMArCS-2) glucose trial |
| Q83825465 | Intensive management of hyperglycaemia in acute coronary syndromes. Study design and rationale of the BIOMArCS 2 glucose trial |
| Q91211669 | International variation in characteristics and clinical outcomes of patients with type 2 diabetes and heart failure: Insights from TECOS |
| Q72560587 | Intracoronary albunex. Its effects on left ventricular hemodynamics, function, and coronary sinus flow in humans |
| Q43494058 | Lenient versus strict rate control in patients with atrial fibrillation |
| Q88424160 | Long-Term Follow-Up of the Randomized (BIOMArCS-2) Glucose Trial: Intensive Glucose Regulation in Hyperglycemic Acute Coronary Syndrome |
| Q42608775 | Long-term Clinical Outcome and MIBI SPECT Parameters in Percutaneous Coronary Interventions |
| Q28220563 | Long-term outcome after an early invasive versus selective invasive treatment strategy in patients with non-ST-elevation acute coronary syndrome and elevated cardiac troponin T (the ICTUS trial): a follow-up study |
| Q40522136 | Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY mana |
| Q90977896 | Longitudinally Measured Fibrinolysis Factors are Strong Predictors of Clinical Outcome in Patients with Chronic Heart Failure: The Bio-SHiFT Study |
| Q71111859 | Low-dose dobutamine echocardiography and rest-redistribution thallium-201 tomography in the assessment of spontaneous recovery of left ventricular function after recent myocardial infarction |
| Q41436714 | Metabolic imaging using F18-fluorodeoxyglucose to assess myocardial viability |
| Q53601215 | Myocardial beta-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[11C]CGP12388. |
| Q43661997 | Myocardial contrast echocardiography can depict thebesian vein outflow in humans |
| Q48870087 | N-terminal pro B-type natriuretic peptide identifies patients with chest pain at high long-term cardiovascular risk |
| Q48229482 | N-terminal pro-brain natriuretic peptide for additional risk stratification in patients with non-ST-elevation acute coronary syndrome and an elevated troponin T: an Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) substu |
| Q41816759 | One-year mortality after a first visit to a cardiology outpatient clinic: a useful performance indicator? |
| Q73099192 | Optimal metabolic conditions during fluorine-18 fluorodeoxyglucose imaging; a comparative study using different protocols |
| Q92371579 | P2Y12 Inhibitor Switching in Response to Routine Notification of CYP2C19 Clopidogrel Metabolizer Status Following Acute Coronary Syndromes |
| Q92676806 | PCSK9 Antibody Alirocumab Attenuates Arterial Wall Inflammation Without Changes in Circulating Inflammatory Markers |
| Q52367424 | Patient work in end-stage heart failure: a prospective longitudinal multiple case study. |
| Q47297971 | Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study |
| Q81470992 | Percutaneous coronary intervention with off-site cardiac surgery backup for acute myocardial infarction as a strategy to reduce door-to-balloon time |
| Q35011439 | Plasma concentration of amino-terminal pro-brain natriuretic peptide in chronic heart failure: prediction of cardiovascular events and interaction with the effects of rosuvastatin: a report from CORONA (Controlled Rosuvastatin Multinational Trial in |
| Q38461756 | Platelet function during extended prasugrel and clopidogrel therapy for patients with ACS treated without revascularization: the TRILOGY ACS platelet function substudy |
| Q33146457 | Possible bradycardic mode of death and successful pacemaker treatment in a large family with features of long QT syndrome type 3 and Brugada syndrome |
| Q40058838 | Prasugrel versus clopidogrel for acute coronary syndromes without revascularization |
| Q38378471 | Predicting the risk of bleeding during dual antiplatelet therapy after acute coronary syndromes |
| Q73565452 | Prediction of improvement of contractile function in patients with ischemic ventricular dysfunction after revascularization by fluorine-18 fluorodeoxyglucose single-photon emission computed tomography |
| Q72256426 | Prediction of improvement of regional left ventricular function after surgical revascularization. A comparison of low-dose dobutamine echocardiography with 201Tl single-photon emission computed tomography |
| Q72848418 | Prediction of improvement of ventricular function after first acute myocardial infarction using low-dose dobutamine stress echocardiography |
| Q71442218 | Prediction of recovery of myocardial dysfunction after revascularization. Comparison of fluorine-18 fluorodeoxyglucose/thallium-201 SPECT, thallium-201 stress-reinjection SPECT and dobutamine echocardiography |
| Q71338714 | Prediction of reversibility of wall motion abnormalities after revascularization using F18-fluorodeoxyglucose single photon emission computed tomography |
| Q57779536 | Predictive Accuracy of Echocardiographic Response of Mildly Dyssynergic Myocardial Segments to Low-Dose Dobutamine |
| Q37102996 | Predictors of fatal and non-fatal outcomes in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA): incremental value of apolipoprotein A-1, high-sensitivity C-reactive peptide and N-terminal pro B-type natriuretic peptide |
| Q57243359 | Prior smoking status, clinical outcomes, and the comparison of ticagrelor with clopidogrel in acute coronary syndromes—Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial |
| Q50632367 | Prognostic implications of a normal dobutamine-atropine stress echocardiogram in patients with chest pain. |
| Q71112066 | Prognostic significance of normal dobutamine-atropine stress sestamibi scintigraphy in women with chest pain |
| Q40932393 | Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain |
| Q44323028 | Prognostic value of predischarge dobutamine stress echocardiography in chest pain patients with a negative cardiac troponin T. |
| Q72260246 | Quantitative angiographic measurements of isolated left anterior descending coronary artery stenosis. Correlation with exercise echocardiography and technetium-99m 2-methoxy isobutyl isonitrile single-photon emission computed tomography |
| Q80147520 | RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II |
| Q95601554 | Rationale and design of the PRAETORIAN-COVID trial: A double-blind, placebo-controlled randomized clinical trial with valsartan for PRevention of Acute rEspiraTORy dIstress syndrome in hospitAlized patieNts with SARS-COV-2 Infection Disease |
| Q91786867 | Rationale, design and baseline characteristics of the effect of ticagrelor on health outcomes in diabetes mellitus patients Intervention study |
| Q36840267 | Relation between ST segment elevation during dobutamine stress test and myocardial viability after a recent myocardial infarction |
| Q71112031 | Relation between contractile response of akinetic segments during dobutamine stress echocardiography and myocardial ischemia assessed by simultaneous thallium-201 single-photon emission computed tomography |
| Q39241362 | Relationship between exercise echocardiography and perfusion single-photon emission computed tomography in patients with single-vessel coronary artery disease |
| Q47394886 | Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial |
| Q37556037 | Relationship of Platelet Reactivity With Bleeding Outcomes During Long-Term Treatment With Dual Antiplatelet Therapy for Medically Managed Patients With Non-ST-Segment Elevation Acute Coronary Syndromes |
| Q43500856 | Renal function as a predictor of outcome in a broad spectrum of patients with heart failure |
| Q92967581 | Repeated Echocardiograms Do Not Provide Incremental Prognostic Value to Single Echocardiographic Assessment in Minimally Symptomatic Patients with Chronic Heart Failure: Results of the Bio-SHiFT Study |
| Q93051217 | Risk Categorization Using New American College of Cardiology/American Heart Association Guidelines for Cholesterol Management and Its Relation to Alirocumab Treatment Following Acute Coronary Syndromes |
| Q34710349 | Rosuvastatin in older patients with systolic heart failure |
| Q53016348 | Ruling out coronary artery disease in women with atypical chest pain: results of calcium score combined with coronary computed tomography angiography and associated radiation exposure. |
| Q80552344 | ST-segment deviation on the admission electrocardiogram, treatment strategy, and outcome in non-ST-elevation acute coronary syndromes A substudy of the Invasive versus Conservative Treatment in Unstable coronary Syndromes (ICTUS) Trial |
| Q81561035 | Safety and efficacy of a nurse-led clinic for post-operative coronary artery bypass grafting patients |
| Q71184967 | Safety and feasibility of dobutamine-atropine stress echocardiography in patients with ischemic left ventricular dysfunction |
| Q77700300 | Safety and utility of atropine addition during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction |
| Q52380491 | Safety of dobutamine-atropine stress echocardiography in patients with suspected or proven coronary artery disease. |
| Q48245548 | Safety of sitagliptin in patients with type 2 diabetes and chronic kidney disease: outcomes from TECOS. |
| Q48632120 | Secondary Prevention of Cardiovascular Disease in Patients With Type 2 Diabetes Mellitus: International Insights From the TECOS Trial (Trial Evaluating Cardiovascular Outcomes With Sitagliptin). |
| Q50969356 | Serially measured circulating miR-22-3p is a biomarker for adverse clinical outcome in patients with chronic heart failure: The Bio-SHiFT study. |
| Q99633698 | Short-term effect of low-dose colchicine on inflammatory biomarkers, lipids, blood count and renal function in chronic coronary artery disease and elevated high-sensitivity C-reactive protein |
| Q72267703 | Stress-induced left ventricular dysfunction in silent and symptomatic myocardial ischemia during dobutamine stress test |
| Q71329711 | T wave normalization during dobutamine stress testing in patients with non-Q wave myocardial infarction. A marker of myocardial ischaemia? |
| Q72564480 | T-wave normalization during dobutamine echocardiography for diagnosis of viable myocardium |
| Q38376674 | Temporal Biomarker Profiling Reveals Longitudinal Changes in Risk of Death or Myocardial Infarction in Non-ST-Segment Elevation Acute Coronary Syndrome |
| Q88430443 | The Prognostic Value of Late Gadolinium-Enhanced Cardiac Magnetic Resonance Imaging in Nonischemic Dilated Cardiomyopathy: A Review and Meta-Analysis |
| Q53499051 | The Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA*CER) trial: study design and rationale. |
| Q43553858 | The direct inverse method: a novel approach to estimate adsorption isotherm parameters |
| Q91206755 | The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics |
| Q68611602 | The effect of multiple-dose oral lomefloxacin on theophylline metabolism in man |
| Q79420675 | The impact of admission plasma glucose on long-term mortality after STEMI and NSTEMI myocardial infarction |
| Q40551728 | The prognostic value of markers of inflammation in patients with troponin T-negative chest pain before discharge from the emergency department. |
| Q43012400 | The value of haemostatic markers in the triage of patients with chest pain presenting with a normal or non-diagnostic ECG. |
| Q34231934 | Thrombin-receptor antagonist vorapaxar in acute coronary syndromes |
| Q50181052 | Ticagrelor for Secondary Prevention of Atherothrombotic Events in Patients With Multivessel Coronary Disease |
| Q93053058 | Ticagrelor in Patients with Stable Coronary Disease and Diabetes |
| Q93104339 | Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-controlled, randomised trial |
| Q38500562 | Ticagrelor versus clopidogrel in acute coronary syndromes in relation to renal function: results from the Platelet Inhibition and Patient Outcomes (PLATO) trial |
| Q35051753 | Ticagrelor versus clopidogrel in patients with acute coronary syndromes intended for non-invasive management: substudy from prospective randomised PLATelet inhibition and patient Outcomes (PLATO) trial |
| Q34404150 | Ticagrelor vs. clopidogrel in patients with acute coronary syndromes and diabetes: a substudy from the PLATelet inhibition and patient Outcomes (PLATO) trial |
| Q34043989 | Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial |
| Q50112803 | Toward personalized risk assessment in patients with chronic heart failure: Detailed temporal patterns of NT-proBNP, troponin T, and CRP in the Bio-SHiFT study |
| Q84212803 | Translational platelet research in patients with coronary artery disease: what are the major knowledge gaps? |
| Q36171388 | Trends in incidence of infective endocarditis at the Medical Center of Alkmaar |
| Q88080433 | Use of the REG1 anticoagulation system in patients with acute coronary syndromes undergoing percutaneous coronary intervention: results from the phase II RADAR-PCI study |
| Q52926132 | Usefulness and limitations of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in patients with left bundle branch block. A multicentre study. |
| Q40766715 | Validation of BARC Bleeding Criteria in Patients With Acute Coronary Syndromes: The TRACER Trial |
| Q50444452 | Vorapaxar with or without clopidogrel after non-ST-segment elevation acute coronary syndromes: results from the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome trial. |
Search more.